Skip to main content
Caplight Logo









Lucid Scientific

Lucid Scientific

Private
Atlanta, GeorgiaHealthcare & Life Scienceshttps://lucidsci.com/

Last Round

Series A

Sep 26, 2023

Total Funding Raised

$10M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Lucid Scientific is a biotechnology company that develops and manufactures the Resipher platform, a system for real-time, non-invasive cellular metabolism analysis used in drug discovery and biological research.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting

AI Layer

Non-AI

Keywords

real-time cellular analysislive cell analysiscellular metabolismoxygen consumption rateOCRmetabolic cell analyzernon-invasive cell analysisdrug discovery toolsbiotechnology toolsoptical oxygen sensorsrazor and blade modellab consumablescancer researchimmunometabolismcell therapy development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lucid Scientific Comparables

Compare Lucid Scientific with similar companies based on industry and business-model similarity.

Lucid Scientific comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Agilent Technologies
81%
Sartorius Aktiengesellschaft
71%
PreSens Precision Sensing
67%

Lucid Scientific Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ASep 26, 2023
SeedSep 18, 2020

Lucid Scientific Investors

Notable investors and investment history

Lucid Scientific investors
InvestorRounds
Dynamk CapitalSeries A, Seed
IAG Capital PartnersSeries A
Georgia Research AllianceSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 119% MoM, reaching 20K.

  • Jul 26, 2026

    Monthly visitors increased 120% MoM, reaching 9.1K.

Lucid Scientific Filings

Explore SEC and related filing metadata, where available.

Lucid Scientific filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Lucid Scientific's valuation, stock price, and market status.

Is Lucid Scientific a public or private company?

Lucid Scientific is a private company.

What is the current stock price of Lucid Scientific?

Lucid Scientific is a private company with no public stock price. No recent secondary market data is available.

How much is Lucid Scientific worth (valuation)?

Valuation information for Lucid Scientific is not publicly available.

Can I buy Lucid Scientific stock?

Lucid Scientific shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Lucid Scientific's last funding round?

Lucid Scientific's most recent funding round was Series A on September 26, 2023.

Who are the main investors in Lucid Scientific?

Key investors in Lucid Scientific include Dynamk Capital, IAG Capital Partners.

Will Lucid Scientific IPO soon?

No public IPO plans have been announced for Lucid Scientific.

How can I track Lucid Scientific secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lucid Scientific's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAtlanta, Georgia
Employee Range16
Year Founded2012
Last FundingSep 26, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?